In order to increase beneficial effects of bioactive compounds in
functional food and dietary supplements, enormous efforts are put in the
technological development of microcapsules. Although these products are
often tailor-made for disease susceptible consumer, the physiological
impact of microcapsule uptake on the respective target consumer has
never been addressed. The present study aimed to assess the relevance of
this aspect by analyzing the impact of milk protein based microcapsules
on experimental inflammatory bowel disease. Long-term feeding of sodium
caseinate or rennet gel microcapsules resulted in significant
alterations in the intestinal microbiota of healthy mice. In TNFARE/wt
mice, a model for chronic ileal inflammation, rennet gel microcapsules
resulted in further increased splenomegaly, whereas ileal inflammation
was unchanged. In IL10(-/-) mice, a model for chronic colitis, both
types of microcapsules induced a local increase of the intestinal
inflammation. The present study is the first to demonstrate that, independent of their cargo, microcapsules have the potential to affect
the intestinal microbiota and to exert unprecedented detrimental effects
on disease-susceptible individuals. In conclusion, the impact of
microcapsule uptake on the respective target consumer groups should be
thoroughly investigated in advance to their commercial use in functional
food or dietary supplements.
«
In order to increase beneficial effects of bioactive compounds in
functional food and dietary supplements, enormous efforts are put in the
technological development of microcapsules. Although these products are
often tailor-made for disease susceptible consumer, the physiological
impact of microcapsule uptake on the respective target consumer has
never been addressed. The present study aimed to assess the relevance of
this aspect by analyzing the impact of milk protein based mi...
»